Overview

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a unicentered phase I/II study to explore the dose of paclitaxel and cisplatin with radiation therapy, and to document the adverse events for further clinical trial.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel